| abstract |
The present invention relates to the field of tissue damage. More specifically, the present invention provides pharmaceutical compositions useful for the treatment of tissue damage. In certain embodiments, the pharmaceutical composition comprises (a) a stem cell mobilizing agent and (b) an immunosuppressive agent or a non-immunosuppressive FK binding protein ligand. The pharmaceutical composition of the present invention can be administered by various routes and administration formulations. |